Dr. Charles M. Rudin, MD, PhD, is a nationally recognized leader in thoracic medical oncology and serves as Chief of Thoracic Oncology and Deputy Director of the Cancer Center at Memorial Sloan Kettering Cancer Center (MSKCC). He holds the Sylvia Hassenfeld Chair in Lung Cancer Research and co-directs the Druckenmiller Center for Lung Cancer Research. He received his MD and PhD from the University of Chicago Pritzker School of Medicine, completed residency and fellowship training there, and later served as founding co-Director of the Upper Aerodigestive Cancer Program at Johns Hopkins before joining MSKCC in 2013. Board-certified in Medical Oncology, Dr. Rudin provides expert care for patients with lung, tracheal, and thymic malignancies, offering both in-person and telehealth consultations.
Why they are a top doctor
Research papers · PubMed
447
Published, peer-reviewed work, the clearest public measure of expertise in a specialty.
Cited by other doctors
91k
How often other doctors and researchers build on their work.
Background
Education
Medical school
University of Chicago Pritzker School of Medicine
Residency
Internal Medicine, University of Chicago Medical Center
Fellowship
Medical Oncology, University of Chicago Medical Center
Board certification
Medical Oncology
Areas of focus
Lung cancer
Awards
Outstanding Investigator Award, National Cancer Institute
Director's Service Award, National Cancer Institute
Paul A. Bunn Lifetime Achievement Award, International Association for the Study of Lung Cancer
Elected Member, Association of American Physicians
Memberships and affiliations
MSK Cancer Center
Druckenmiller Center for Lung Cancer Research, MSK
Scientific Advisory Board, LUNGevity Foundation
NCI Small Cell Lung Cancer Research Consortium
National Cancer Institute Board of Scientific Advisors
American Society of Clinical Oncology
American Association for Cancer Research
International Association for the Study of Lung Cancer
Selected publications
Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer.
Cellular ATP demand creates metabolically distinct subpopulations of mitochondria.
Regenerative lineages and immune-mediated pruning in lung cancer metastasis.
Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients.
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.
Tumor mutational load predicts survival after immunotherapy across multiple cancer types.
Medical OncologistMedical Oncologist · New York, NY · New York · NY
Known for contributions to the understanding of oncogene-driven lung cancers and the development of targeted therapies. Treats lung cancer and thymoma and thymic carcinoma. Works as a thoracic medical oncologist. Based in New York. Chosen on merit.
Medical OncologistMedical Oncologist · New York, NY · New York · NY
Renowned for leadership in the development of novel treatment strategies for non-small cell lung cancer (NSCLC). Treats lung cancer. Works as a thoracic medical oncologist. Based in New York. Chosen on merit.
Medical OncologistMedical Oncologist · New York, NY · New York · NY
Developed novel methods to model viral evolution topology and identify gene fusions in cancer. Treats lung cancer, non-small cell lung cancer and small cell lung cancer. Works as a thoracic medical oncologist. Based in New York. Chosen on merit.